Current Treatment in Advanced Renal Cell Carcinoma (RCC): Impact of Targeted Therapies in the Management of RCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current Treatment in Advanced Renal Cell Carcinoma (RCC): Impact of Targeted Therapies in the Management of RCC

Published:2007-03 Issue:7 Volume:6 Page:484-491
ISSN:1569-9056
Container-title:European Urology Supplements
language:en
Short-container-title:European Urology Supplements

Author:

Bellmunt Joaquim

Publisher

Elsevier BV

Subject

Urology

Reference51 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2004

3. Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group Study;Kish;Cancer,1994

4. Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group;Mertens;Ann Oncol,1993

5. Capecitabine in the treatment of metastatic renal cell carcinoma;Oevermann;Br J Cancer,2000

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, development and evaluation of self-microemulsifying drug delivery system of pazopanib for enhanced dissolution rate and cytotoxic potential;Journal of Drug Delivery Science and Technology;2023-02

2. Efficient Production of a Bioactive Bevacizumab Monoclonal Antibody Using the 2A Self-cleavage Peptide in Transgenic Rice Callus;Frontiers in Plant Science;2016-08-09

3. Carcinoma renal de células claras metastásico a la base de la lengua y al músculo bíceps braquial;Gaceta Mexicana de Oncología;2015-05

4. Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms;BioMed Research International;2015

5. How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma;Value in Health;2010-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3